Clinical Trials Logo

Filter by:
NCT ID: NCT03702478 Completed - Quality of Life Clinical Trials

Quality of Life in Patients With and Without a Parastomal Bulge

Start date: August 13, 2018
Phase:
Study type: Observational

It is not well-established whether a parastomal bulge impacts stoma patients HRQoL or if HRQOL differs according to the underlying disease or type of stoma. In this large cross-sectinal study stoma patients with and without a parastomal bulge are asked about their health-related quality of life and stomarelated quality of life. Stoma patients are identified in the danish stoma database and contacted two times by email. Non-responders are sent a paper booklet.

NCT ID: NCT03700060 Completed - Clinical trials for Urinary Tract Infections

Communication and Compliance for Antibiotic Prescribing by General Practice to Nursing Home Residents With Suspected UTI

Start date: April 3, 2018
Phase:
Study type: Observational

Antibiotic resistance is becoming a bigger problem. If the problem remains unsolved, the WHO predicts a return to the pre-antibiotic era. Overtreatment with antibiotics drives development of resistant bacteria and adverse events in patients, thus identification and rectifying factors leading to unnecessary antibiotic prescriptions are a public health problem. Urinary Tract Infections (UTIs) are the most commonly diagnosed infection in nursing homes (NH). A prevalence study showed that in up to 76% of all antibiotic prescriptions in Danish NHs the indication was UTI. In this particular group of patients with suspected UTI, the literature has repeatedly shown that a vast amount of these antibiotic courses are inappropriate. As people age, the prevalence of asymptomatic bacteriuria increases significantly. Asymptomatic bacteriuria is a condition that should not be treated with antibiotics. Thus, the treatment decision in this group should not rely on the result of urinary testing and should only commence, when classical urinary symptoms are present. Urinary testing of NH residents is one of the drivers of overtreatment. Therefore, a recent Danish guideline from Institute of Rational Pharmacology (IRF) on elderly with suspected UTI suggest that urine culture should only be performed when typical urinary symptoms are present and that antibiotic prescribing should be delayed until the result of the culture is available whenever possible. It is unknown to what extent Danish GPs follows these guidelines. NH residents are often immobile, therefore; the diagnostic process of UTI in NH residents differs from the norm, which could also explain some part of the inappropriate prescribing. Immobility introduces physical distance between patient and GP because the patient is unable to visit the General Practitioners office. Because home visits are rare, when a UTI is suspected, NH staff usually contacts the GP in writing, over the phone and occasionally in person to relate the patient history and physical findings. When another link in the communication chain between patient and GP is added, clinical information passes through additional health professionals and the risk of communication error and misunderstanding increases. Some forms of communications may be more suited to fit this setting than others. When communicating in person, it is possible to take non-verbal cues into account and immediately clear up insecurities. Communication by phone eliminates non-verbal cues, but a dialog about unclarified aspects is still attainable. Written communication, however, has none of the clarifying traits of the former, and to elaborate on the content the GP will have to contact the NH, which takes time in an already packed schedule. The investigators hypothesize that the more direct the contact form, the better the quality of clinical information, which leads to increased compliance with guidelines. Thus by proxy, our hypothesis becomes that compliance to guidelines increases with directness of contact form. The aim of this study is to investigate to which degree the guidelines on antibiotic prescribing for NH residents with suspected UTI are followed and how the communication form affects adherence to guidelines.

NCT ID: NCT03698422 Completed - Clinical trials for Chronic Kidney Diseases

Diurnal Variation in Markers of Mineral and Bone Disease in Chronic Kidney Disease

Start date: October 3, 2018
Phase:
Study type: Observational

The purpose of this study is to examine whether there are diurnal variations in magnesium and other markers related to mineral metabolism in blood from patients with chronic kidney disease (CKD) compared to healthy controls.

NCT ID: NCT03697759 Completed - Low Back Pain Clinical Trials

A Decision Support System for Self-management of Low Back Pain - PILOTSTUDY

selfBACK
Start date: August 20, 2018
Phase: N/A
Study type: Interventional

The pilot study precedes a larger randomized controlled trial, to be starting in February 2019. In this pilot study all participants are allocated to the intervention group. The intervention consists of a digital decision support system delivering a weekly plan of suggested activities that the participant can use to self-manage their low back pain. The plan is presented to the participant in the selfBACK app.

NCT ID: NCT03697590 Completed - Keratosis, Actinic Clinical Trials

Photodynamic Therapy of Actinic Keratosis of the Face and Scalp With and Without Prior Curettage

Start date: June 1, 2017
Phase: Phase 4
Study type: Interventional

Guidelines for photodynamic therapy (PDT) of actinic keratosis recommend pretreatment with curettage. The impact of curettage on the treatment effect is, however, not known. The present study aimed to evaluate whether daylight-PDT without curettage would reduce treatment effect compared to daylight-PDT with curettage.

NCT ID: NCT03693833 Completed - Psoriatic Arthritis Clinical Trials

CBD Treatment in Hand Osteoarthritis and Psoriatic Arthritis.

NordCAN
Start date: November 28, 2018
Phase: Phase 2
Study type: Interventional

A randomized, placebo-controlled trial with blinded outcome assessments will be conducted to evaluate the efficacy and safety of CBD in patients with Hand-OA and PsA during a 12-week treatment period.

NCT ID: NCT03691844 Completed - Clinical trials for Osteoarthritis, Knee

AMZ001 for the Treatment of Knee Osteoarthritis Symptoms

Start date: October 4, 2018
Phase: Phase 2/Phase 3
Study type: Interventional

This is a multicenter, randomized, double-blind, placebo-controlled, parallel group, 4-week trial of a formulation of AMZ001 once or twice daily versus placebo twice daily, including a single-blind treatment group with a commercial gel four times daily.

NCT ID: NCT03691298 Completed - Instability, Joint Clinical Trials

Safety and Performance of the SUTUREFIX ULTRA and SUTUREFIX CURVED Suture Anchors in Shoulder and Hip Arthroscopic Repair

SuturefixUltra
Start date: October 17, 2018
Phase:
Study type: Observational

The scientific justification is to fulfill post-market clinical requirements in order to support re-certification of the CE-Mark for this marketed product and to look into safety and efficacy.

NCT ID: NCT03690726 Completed - Spinal Cord Injury Clinical Trials

The Effects of rTMS in Rehabilitation Following Spinal Cord Injury

Start date: January 2, 2019
Phase: N/A
Study type: Interventional

The project will investigate whether repetitive transcranial magnetic stimulation (rTMS) can be used to potentiate/prime spinal cord injured patients' nervous systems for more intense rehabilitation exercise of longer duration - thus leading to greater recovery of motion function. The technique, in which a magnetic coil is positioned above the scalp and forms a magnetic field that activates the desired center of the brain (eg motor cortex), is used in clinical practice for the treatment of a number of disorders. However, although a combination of rTMS and gait training in SCI patients previously has proven beneficial, it is unknown whether additional functional gains can be achieved by combining rTMS and supervised, high-intensity resistance training. In this project, 30 newly-admitted patients will be recruited and randomized to receive either active rTMS and strength training (n = 15) or sham (imitated) rTMS + strength training, in parallel with standard care. The investigators hypothesize that the active rTMS group will have superior gains in locomotor function and muscle mass, compared to the sham group.

NCT ID: NCT03690206 Completed - Clinical trials for Short Bowel Syndrome

Efficacy And Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome (SBS)

EASE SBS 1
Start date: October 4, 2018
Phase: Phase 3
Study type: Interventional

The primary objective of the trial is to confirm the efficacy of glepaglutide in reducing parenteral support volume in patients with short bowel syndrome. Glepaglutide is the International Nonproprietary Name and USAN for ZP1848.